Catalysts for Jubilant Generics Ltd
17 tracked
Jan 30, 2026
approval
VALACYCLOVIR HYDROCHLORIDE — FDA approval
VALACYCLOVIR HYDROCHLORIDE
→
Nov 5, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 1, 2025
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Apr 10, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Apr 10, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Apr 17, 2023
approval
VALACYCLOVIR HYDROCHLORIDE — FDA approval
VALACYCLOVIR HYDROCHLORIDE
→
Apr 17, 2023
approval
VALACYCLOVIR HYDROCHLORIDE — FDA approval
VALACYCLOVIR HYDROCHLORIDE
→
Nov 1, 2022
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
Nov 30, 2020
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
Dec 2, 2016
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
Jun 14, 2015
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Jun 14, 2015
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Feb 23, 2015
approval
IRBESARTAN — FDA approval
IRBESARTAN
→
Oct 11, 2013
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 30, 2012
approval
VALACYCLOVIR HYDROCHLORIDE — FDA approval
VALACYCLOVIR HYDROCHLORIDE
→
Apr 3, 2012
approval
VALACYCLOVIR HYDROCHLORIDE — FDA approval
VALACYCLOVIR HYDROCHLORIDE
→